ICU Medical (ICUI) to Release Quarterly Earnings on Wednesday

ICU Medical (NASDAQ:ICUI) is scheduled to issue its quarterly earnings data after the market closes on Wednesday, August 7th. Analysts expect the company to announce earnings of $0.98 per share for the quarter. Parties that wish to register for the company’s conference call can do so using this link.

ICU Medical (NASDAQ:ICUI) last posted its quarterly earnings results on Tuesday, May 7th. The medical instruments supplier reported $0.60 EPS for the quarter, beating the consensus estimate of $0.54 by $0.06. ICU Medical had a negative net margin of 2.63% and a positive return on equity of 5.38%. The business had revenue of $566.66 million for the quarter, compared to analysts’ expectations of $553.15 million. On average, analysts expect ICU Medical to post $4 EPS for the current fiscal year and $5 EPS for the next fiscal year.

ICU Medical Stock Up 0.4 %

ICU Medical stock opened at $127.06 on Wednesday. The company’s fifty day simple moving average is $116.86 and its 200-day simple moving average is $106.16. The company has a debt-to-equity ratio of 0.76, a quick ratio of 1.09 and a current ratio of 2.61. ICU Medical has a 12 month low of $78.28 and a 12 month high of $179.01.

Analysts Set New Price Targets

Several equities research analysts recently issued reports on the stock. Needham & Company LLC assumed coverage on shares of ICU Medical in a research note on Friday, June 21st. They issued a “hold” rating for the company. Raymond James raised shares of ICU Medical from a “market perform” rating to an “outperform” rating and set a $135.00 price objective for the company in a research note on Monday, June 17th. Two equities research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $127.00.

Insider Activity at ICU Medical

In related news, COO Christian B. Voigtlander sold 12,539 shares of ICU Medical stock in a transaction on Thursday, May 30th. The shares were sold at an average price of $103.95, for a total value of $1,303,429.05. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. In other ICU Medical news, COO Christian B. Voigtlander sold 12,539 shares of the business’s stock in a transaction on Thursday, May 30th. The shares were sold at an average price of $103.95, for a total transaction of $1,303,429.05. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, insider Ben Sousa sold 2,000 shares of the business’s stock in a transaction on Friday, May 10th. The stock was sold at an average price of $105.55, for a total transaction of $211,100.00. Following the transaction, the insider now directly owns 1,319 shares of the company’s stock, valued at approximately $139,220.45. The disclosure for this sale can be found here. In the last 90 days, insiders sold 14,839 shares of company stock valued at $1,546,014. Insiders own 6.70% of the company’s stock.

About ICU Medical

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.